Also, two open-label trials using 400 mg/day of riboflavin have decreased migraine attack frequency from 4 attacks per month to 2 attacks per month, and from 8.7 attacks per month to 2.9 attacks per month, respectively (100)
This means, in part, eating enough protein and making strength training a priority - both of which I can help with
However, while technical limitations may exist regarding adequate GSH rescue, we cannot rule out non-canonical and non-enzymatic functions of GCLC contributing to lipid-related phenotypes
Food and Drug Administration (FDA) in 2005 for the treatment of type 2 diabetes
#Porphyria #RareDisease #ClinicalPharmacy #Hematology #MedicalEducation #HealthcareProfessionals To view or add a comment, sign in I'm pleased to share our latest systematic review and meta-analysis, now published in Endocrinology, Diabetes & Metabolism